SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-020919
Filing Date
2014-04-04
Accepted
2014-04-04 17:00:24
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v371804_10k.htm 10-K 879752
2 EXHIBIT 23.1 v371804_ex23-1.htm EX-23.1 2640
3 EXHIBIT 31.1 v371804_ex31-1.htm EX-31.1 9668
4 EXHIBIT 31.2 v371804_ex31-2.htm EX-31.2 9964
5 EXHIBIT 32.1 v371804_ex32-1.htm EX-32.1 5010
  Complete submission text file 0001144204-14-020919.txt   6077588

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgrx-20131231.xml EX-101.INS 960830
7 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20131231.xsd EX-101.SCH 55299
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20131231_cal.xml EX-101.CAL 28030
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20131231_def.xml EX-101.DEF 239541
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20131231_lab.xml EX-101.LAB 334607
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20131231_pre.xml EX-101.PRE 297218
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 14746616
SIC: 2834 Pharmaceutical Preparations